Poster (Scientific congresses and symposiums)
Botulinum Neurotoxin type A is effective to treat peripheral myoclonus post-amputation
Briand, Marie-Michèle; Boudier-Réverêt, Mathieu; Rodrigue, Xavier et al.
201934e Congrès de la Société Française de Médecine Physique et Réadaptation
 

Files


Full Text
SOFMER2019_final.pdf
Publisher postprint (870.25 kB)
Download

All documents in ORBi are protected by a user license.

Send to



Details



Keywords :
Amputation; myoclonus; Botulinum Neurotoxin type A
Abstract :
[en] Peripheral myoclonus is a rare post-amputation complication characterized by sudden, brief and sometimes repetitive muscle contractions. BoNT-A prevents the release of the neurotransmitter acetylcholine at the axon ending of the neuromuscular junction and blocks contraction. Here, we present the case of a 57-year-old man with below-knee amputation due to infected post-traumatic aneurysm of the popliteal artery developed myoclonus in his stump who benefited from a 2-year Botulinum Neurotoxin type A injection treatment.
Disciplines :
Neurology
Author, co-author :
Briand, Marie-Michèle ;  Université de Liège - ULiège > Consciousness-Coma Science Group
Boudier-Réverêt, Mathieu
Rodrigue, Xavier
Sirois, Geneviève
Language :
English
Title :
Botulinum Neurotoxin type A is effective to treat peripheral myoclonus post-amputation
Publication date :
18 October 2019
Event name :
34e Congrès de la Société Française de Médecine Physique et Réadaptation
Event organizer :
Société Française de Médecine Physique et Réadaptation
Event place :
Bordeaux, France
Event date :
du 17 octobre 2019 au 19 octobre 2019
Audience :
International
Available on ORBi :
since 23 October 2019

Statistics


Number of views
50 (4 by ULiège)
Number of downloads
12 (0 by ULiège)

Bibliography


Similar publications



Contact ORBi